Top Abstract Purchase Related
Home
>
Node
>
Subnode

Molecular and clinical conditions associated with venous thromboembolism in oncological patients

Di Micco, P.; Amitrano, M.; Niglio, A.; Fontanella, A.

Experimental Oncology 28(3): 194-197

2006

ISSN/ISBN: 1812-9269
PMID: 17080011
Document Number: 601665
The association between cancer and thrombophilia has been known since 1865 since Trousseau described it. However in the last three decades an increased interest has been raised on this issue related to several molecular and condition that are involved in the daily management of oncological patients. This brief review has been focused on molecular conditions underlying cancer acquired thrombophilia then to further clinical aspects inducing thrombophilia in oncological patients such as surgery, chemotherapy, concomitant medical illness and inherited thrombophilia.

Document emailed within 1 workday
Secure & encrypted payments

Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Couturaud, F.; Julian, J.A.; Kearon, C. 2001: Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis Thrombosis and Haemostasis 86(4): 980-984
Jacobsen, A.F.; Qvigstad, E.; Sandset, P.M. 2000: Treatment of venous thromboembolism in pregnancy with low molecular weight heparin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2448-2449
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Matsagas, M.I. 2004: Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview International Angiology: a Journal of the International Union of Angiology 23(4): 305-316
Bergqvist, D. 1990: Low molecular weight heparin--preventive supplementation against postoperative venous thromboembolism Lakartidningen 87(8): 562-564
Iorio, A.; Agnelli, G. 2000: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis Archives of Internal Medicine 160(15): 2327-2332
Caprini, J.A.; Arcelus, J.; Sehgal, L.R.; Cohen, E.B.; Reyna, J.J. 2002: The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States International Angiology: a Journal of the International Union of Angiology 21(1): 78-85
Mcgarry, L.J.; Thompson, D. 2004: Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice Clinical Therapeutics 26(3): 419-430
Liu, F-fang.; Zhai, Z-guo.; Yang, Y-hua.; Wang, J.; Wang, C. 2013: Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism Zhonghua Yi Xue Za Zhi 93(24): 1860-1863
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
Di Minno, G.; Agnes, R.; Tufano, A. 2005: Venous thromboembolism: which patients are truly at risk? Acta Bio-Medica: Atenei Parmensis 76(Suppl 1): 31-32
Selva-O'Callaghan, A.; Fernández-Luque, A.; Martínez-Gómez, X.; Labirua-Iturburu, A.; Vilardell-Tarrés, M. 2011: Venous thromboembolism in patients with dermatomyositis and polymyositis Clinical and Experimental Rheumatology 29(5): 846-849
Khammassi, N.; Haykel, A.; Cherif, O. 2012: Management of venous thromboembolism in psychiatric patients La Tunisie Medicale 90(1): 1-5
Monreal, M.; Fernandez-Llamazares, J.; Perandreu, J.; Urrutia, A.; Sahuquillo, J.C.; Contel, E. 1997: Occult cancer in patients with venous thromboembolism: which patients, which cancers Thrombosis and Haemostasis 78(5): 1316-1318
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147
Junod, A. 2015: Risk scores for the development of venous thromboembolism in ambulatory patients and in patients hospitalized for acute medical disease Revue Medicale Suisse 11(492): 2030-2036
Meyer, G. 2011: Secondary prevention of venous thromboembolism in patients with cancer La Revue du Praticien 61(9): 1249-1251